5PSQ-050 Neuropsychiatric adverse effects on dolutegravir: experience in a third-level hospital

BACKGROUND: Dolutegravir (DTG), a second-generation integrase strand transfer inhibitor (INSTI), is currently among the most commonly used antiretroviral agents. Recent reports have raised concerns about their safety, especially with regard to neuropsychiatric adverse effects (neuropsychiatric AEs)....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Hosp Pharm
Main Authors: Lopez, TLopez Viñau, de Molina, MD López Malo, de Vicente, M Sáez-Torres, Donoso, J López-Santamaria, Torres, IReyes, Parada, J Hernández
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Group 2018
Fag:
Section 5: Patient safety and quality assurance
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535272/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.404
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker